Abstract
BackgroundThere is great interest in developing new treatment approaches for systemic lupus erythematosus (SLE), but the biologic therapies under investigation have yielded disappointing results. Recently the nuclear export protein XPO1...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
